Christopher F Sharpley1, Vicki Bitsika. 1. Brain-Behaviour Research Group, University of New England, NSW, Australia. csharpley@onthenet.com.au
Abstract
OBJECTIVE: To evaluate the literature supporting four potential criteria for deciding whether to use psychotherapy or pharmacology when treating depression. METHOD: Literature review of the evidence from the last 10 years on presenting patient's demographics, aetiology, comorbidity, and genetic factors, as predictors of treatment outcome efficacy. RESULTS: Demographic information has little support as a potential criteria for decision-making; aetiology (melancholic vs. non-melancholic) has significant support; presence of personality disorder comorbidity is unproven as a criterion but may have some value; genetic predisposition has the strongest evidence supporting it as a criteria for treatment decision-making. CONCLUSION: Although some presenting cases will be easier to classify than others, there are substantial data supporting the screening of patients according to three of these criteria.
OBJECTIVE: To evaluate the literature supporting four potential criteria for deciding whether to use psychotherapy or pharmacology when treating depression. METHOD: Literature review of the evidence from the last 10 years on presenting patient's demographics, aetiology, comorbidity, and genetic factors, as predictors of treatment outcome efficacy. RESULTS: Demographic information has little support as a potential criteria for decision-making; aetiology (melancholic vs. non-melancholic) has significant support; presence of personality disorder comorbidity is unproven as a criterion but may have some value; genetic predisposition has the strongest evidence supporting it as a criteria for treatment decision-making. CONCLUSION: Although some presenting cases will be easier to classify than others, there are substantial data supporting the screening of patients according to three of these criteria.